Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes
April 24, 2025 01:00 ET | Source: Zealand Pharma Press release –…
Zealand Pharma launches long-term incentive programs for Zealand Pharmas Board of Directors, Corporate Management and employees for 2025
April 19, 2025 16:00 ET | Source: Zealand Pharma Company announcement –…
Total number of shares and voting rights in Zealand Pharma as of March 31, 2025
March 31, 2025 17:00 ET | Source: Zealand Pharma Company announcement –…
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 53 / 2024 Transactions in Zealand Pharma shares…
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
Company announcement – No. 52 / 2024 Zealand Pharma major shareholder announcement:…
Zealand Pharma to participate in the Jefferies London Healthcare Conference
Press Release – No. 11 / 2024 Zealand Pharma to participate in…